Portfolio Development

OUTSOURCED 
PRODUCT DEVELOPMENT UNIT

WESSX has the expertise to be your product development unit; guiding products through clinical to market authorization.
  • Fast track guidance
  • Clinical trial governance
  • CRO and CMO assessment and selection

Acquisition of new products can be a time consuming and inefficient endeavor.

WESSX can reduce the cost, time and effort required to find in-licensing or acquisition targets

WESSX utilizes an extensive product development network with over 200 person years experience in assessing and evaluating marketed, clinical and pre-clinical stage products.

Wessx global experts are able to support with:

TECH. TRANSFER & COMPLIANCE

Resources required to manage tech. transfers, CMOs, CROs etc. can be overwhelming.

Manage transfer of manufacturing and logistics activities
Manage manufacturing site acquisitions and divestments
Ensure that contractors meet to all regulatory requirements
Supervise remediation of manufacturing facilities following agency non-compliance actions (warning letters etc.)
Manage CMOs to ensure compliance with GMP requirements
Manage CMOs to ensure compliance with GMP requirements
Negotiate and manage CRO activities for clinical efficiency

Working together

Contact Silvia Bendiner

Executive Partner

+1(407)607-4868 (USA)
+39 3331415067 (ITALY)
sbendiner@wessx.com

WESSX Footprint

Argentina, Australia, Brazil, Canada, Chile, The Netherlands Colombia, Mexico, United Kingdom, United States, Puerto Rico.

Your Message

    Scroll to Top